Literature DB >> 16608980

Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance.

G Metro1, G Finocchiaro, F Cappuzzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16608980     DOI： 10.1093/annonc/mdj920

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

Review 1.  Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

Authors:  S A Kono; L E Heasley; R C Doebele; D R Camidge
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

Review 2.  KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

Authors:  J H J M van Krieken; A Jung; T Kirchner; F Carneiro; R Seruca; F T Bosman; P Quirke; J F Fléjou; T Plato Hansen; G de Hertogh; P Jares; C Langner; G Hoefler; M Ligtenberg; D Tiniakos; S Tejpar; G Bevilacqua; A Ensari
Journal:  Virchows Arch       Date:  2008-09-18       Impact factor: 4.064

3.  Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer.

Authors:  Hui-Jun Zhu; Mikako Ogawa; Yasuhiro Magata; Masahiko Hirata; Yoshiro Ohmomo; Harumi Sakahara
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

4.  FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

Authors:  Richard E Francis; Stephen S Myatt; Janna Krol; Johan Hartman; Barrie Peck; Ursula B McGovern; Jun Wang; Stephanie K Guest; Aleksandra Filipovic; Ondrej Gojis; Carlo Palmieri; David Peston; Sami Shousha; Qunyan Yu; Piotr Sicinski; R Charles Coombes; Eric W-F Lam
Journal:  Int J Oncol       Date:  2009-07       Impact factor: 5.650

5.  Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer.

Authors:  Laura Casorzo; Mara Corigliano; Paolo Ferrero; Tiziana Venesio; Mauro Risio
Journal:  Diagn Pathol       Date:  2009-11-04       Impact factor: 2.644

Review 6.  EGFR-mutated lung cancer: a paradigm of molecular oncology.

Authors:  Zhenfeng Zhang; Amy L Stiegler; Titus J Boggon; Susumu Kobayashi; Balazs Halmos
Journal:  Oncotarget       Date:  2010-11

Review 7.  Receptor Tyrosine Kinase-Targeted Cancer Therapy.

Authors:  Toshimitsu Yamaoka; Sojiro Kusumoto; Koichi Ando; Motoi Ohba; Tohru Ohmori
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 8.  [A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer].

Authors:  Ramaswamy Govindan
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

Review 9.  The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.

Authors:  Zahra Asadzadeh; Noora Karim Ahangar; Hajar Alemohammad; Basira Najafzadeh; Nima Hemmat; Afshin Derakhshani; Amir Baghbanzadeh; Hossein Bannazadeh Baghi; Darya Javadrashid; Souzan Najafi; Meriadeg Ar Gouilh; Behzad Baradaran
Journal:  Arch Virol       Date:  2021-01-18       Impact factor: 2.685
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.